Eye-care drugmaker Alcon said on Wednesday that the U.S. Food and Drug Administration has approved its treatment for dry eye disease (DED).

Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S.

Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first ...

The active ingredient in Tryptyr is acoltremon, an agonist of transient receptor potential melastatin 8 thermoreceptors.

The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear ...

Using eye drops incorrectly — for instance, applying two or more types too close together — may also increase dry eye risk. If your doctor prescribes eye drops, be sure to follow the ...

Eye creams are an oft-neglected part of many people’s skin care routines. Whether you think they’re completely unnecessary or ...

Ointments have the advantage of increased dwell time in the eye, but often patients and parents of children prefer drops, and no therapeutic advantage of one over the other has been demonstrated.

Compr Ophthalmol Update. 2005;6(2):85-101. Systemic corticosteroids are used in the treatment of severe inflammatory conditions of the eye, such as posterior uveitis or scleritis. Systemic ...